Search Results - "Eichler, Iris"
-
1
Reduced auditory evoked gamma-band response and schizophrenia-like clinical symptoms under subanesthetic ketamine
Published in Neuropsychopharmacology (New York, N.Y.) (01-06-2019)“…Abnormal gamma-band oscillations (GBO) have been frequently associated with the pathophysiology of schizophrenia. GBO are modulated by glutamate, a…”
Get full text
Journal Article -
2
Altered Signaling in the Descending Pain-modulatory System after Short-Term Infusion of the μ-Opioid Agonist Remifentanil
Published in The Journal of neuroscience (07-03-2018)“…μ-Opioid receptor agonists are widely used within the contemporary treatment of pain, but abrupt opioid suspension, even after short-term infusion, can…”
Get full text
Journal Article -
3
Alterations in interhemispheric gamma-band connectivity are related to the emergence of auditory verbal hallucinations in healthy subjects during NMDA-receptor blockade
Published in Neuropsychopharmacology (New York, N.Y.) (01-06-2018)“…Auditory verbal hallucinations (AVH) are a common positive symptom of schizophrenia. Excitatory-to-inhibitory (E/I) imbalance related to disturbed…”
Get full text
Journal Article -
4
Quantitative Sensory Changes Following Gasserian Ganglion Radiofrequency Thermocoagulation in Patients with Medical Refractory Trigeminal Neuralgia: A Prospective Consecutive Case Series
Published in Journal of neurological surgery. Part A, Central European neurosurgery (01-09-2020)“…Microsurgical vascular nerve decompression and percutaneous ablative interventions aiming at the Gasserian ganglion are promising treatment modalities for…”
Get more information
Journal Article -
5
Positive Treatment Expectancies Reduce Clinical Pain and Perceived Limitations in Movement Ability Despite Increased Experimental Pain: A Randomized Controlled Trial on Sham Opioid Infusion in Patients with Chronic Back Pain
Published in Psychotherapy and psychosomatics (01-01-2019)“…Increasing evidence for the efficacy of analgesic placebo effects in laboratory studies with healthy persons raises the question whether placebos could be used…”
Get more information
Journal Article -
6
Glutamatergic deficit and schizophrenia-like negative symptoms: new evidence from ketamine-induced mismatch negativity alterations in healthy male humans
Published in Journal of psychiatry & neuroscience (01-07-2017)“…Targeting the -methyl-D-aspartate receptor (NMDAR) is a major translational approach for treating negative symptoms of schizophrenia. Ketamine comprehensively…”
Get full text
Journal Article